Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston
4
×
boston blog main
boston top stories
deals
4
×
life sciences
national blog main
fda
investing
national top stories
san francisco blog main
startups
clinical trials
medical devices
new york blog main
san diego blog main
san francisco top stories
vc
venture capital
arrowmark partners
atrial fibrillation
azacitidine
beta bionics
beta-thalassemia
bigfoot biomedical
biofourmis
biovotion
boston scientific
boston university
chugai pharmaceutical
clinical trial
congenital hyperinsulinism
cryterion medical
dacogen
decitabine
dexcom
diabetes
dna
drug delivery
edbi
What
startup
4
×
developing
device
million
patients
therapeutics
acquire
adding
aims
analytics
approach
atrial
based
beta
biofourmis
bionics
biotech
blood
boston
business
called
closed
continues
cryterion
data
deal
debuts
devices
diabetes
digital
driven
drugs
employs
epigenetic
epigenetics
fibrillation
field
flagship’s
globally
hauls
Language
unset
Current search:
biotech
×
deals
×
startup
×
boston
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion